Accelerators for Hadrontherapy -- Present & Future --

Similar documents
Feasibility study of TULIP: a TUrning

TERA CONTRIBUTIONS TO PARTNER

Overview and Status of the Austrian Particle Therapy Facility MedAustron. Peter Urschütz

Advanced Linac Solutions for Hadrontherapy

Development of beam delivery systems for proton (ion) therapy

Unconventional Acceleration Systems for Proton Radiotherapy

Future Trends in Linacs

Dielectric Wall Accelerator (DWA) and Distal Edge Tracking Proton Delivery System Rock Mackie Professor Dept of Medical Physics UW Madison Co-Founder

ACCELERATORS AND MEDICAL PHYSICS 3

CERN Medical Applications. Giovanni Porcellana. Medical Applications Officer. Knowledge Transfer Accelerating Innovation

Particle Beam Technology and Delivery

Hadron Therapy Medical Applications

HEATHER. HElium ion Acceleration for radiotherapy. Jordan Taylor, Rob Edgecock University of Huddersfield Carol Johnstone, Fermilab

Towards efficient and accurate particle transport simulation in medical applications

High-gradient X-band RF technology for CLIC and beyond

Cyclinac Medical Accelerators Using Pulsed C 6+ /H 2

Introduction to Medical Physics

Medical Applications of Particle Accelerators

Radiation protection issues in proton therapy

Gamma-ray emission by proton beam interaction with injected Boron atoms for medical imaging. Giada Petringa - Laboratori Nazionali del Sud -

Engines of Discovery

Physics of Novel Radiation Modalities Particles and Isotopes. Todd Pawlicki, Ph.D. UC San Diego

Carbon/proton therapy: A novel gantry design

Proposal to convert TLS Booster for hadron accelerator

Radiation Shielding of a 230 MeV Proton Cyclotron For Cancer Therapy

Markus Roth TU Darmstadt

Introduction to Medical Physics

Hadron cancer therapy complex using nonscaling fixed field alternating gradient accelerator and gantry design

S-Band side coupled drift tube linac

Best Particle Therapy, Inc. is Developing a Highly Revolutionary New Treatment for Cancer Therapy

ACCELERATORS AND MEDICAL PHYSICS

PARTICLE BEAMS, TOOLS FOR MODERN SCIENCE AND MEDICINE Hans-H. Braun, CERN

Università degli Studi di Catania

Squeezing the proton. towards small proton therapy systems. Roelf Slopsema. M.Sc. / UF Health Proton Therapy Institute

FFAG Accelerators. CERN Introductory Accelerator School Prague, September 2014

Short Introduction to CLIC and CTF3, Technologies for Future Linear Colliders

LINACS FOR HADRONTHERAPY *

A Project to convert TLS Booster to hadron accelerator 1. Basic design. 2. The injection systems:

Spawning Neutrons, Protons, Electrons and Photons from Universities to Society

Electromagnetic characterization of big aperture magnet used in particle beam cancer therapy

A NOVEL DESIGN OF A CYCLOTRON BASED ACCELERATOR SYSTEM FOR MULTI-ION THERAPY

Design of a proton therapy synchrotron. A Dosage Calculation Example

Outline. Physics of Charge Particle Motion. Physics of Charge Particle Motion 7/31/2014. Proton Therapy I: Basic Proton Therapy

China high-intensity accelerator technology developments for Neutron Sources & ADS

Radiotherapy Hadrons: new devices

M d e i di l ca A pplilli t ca i ttions o f P arti ttic ti l P e h Physics Saverio Braccini INSEL

Non-Scaling Fixed Field Gradient Accelerator (FFAG) Design for the Proton and Carbon Therapy *

Introduction to Particle Accelerators & CESR-C

SPARCLAB. Source For Plasma Accelerators and Radiation Compton with Laser And Beam

The heavy ion irradiation facility at KVI-CART

PARTICLE ACCELERATORS AND PEOPLE

Small Synchrotrons. Michael Benedikt. CERN, AB-Department. CAS, Zeegse, 30/05/05 Small Synchrotrons M. Benedikt 1

Why do we accelerate particles?

Secondary Particles Produced by Hadron Therapy

8/3/2016. Chia-Ho, Hua St. Jude Children's Research Hospital. Kevin Teo The Hospital of the University of Pennsylvania

Multi-Purpose Accelerator-Accumulator ITEP-TWAC for Nuclear Physics and Practical Applications

Medical Applications at the University of Huddersfield

Summary Talk Alternative Accelerator for Therapy. Andrew M. Sessler Lawrence Berkeley National Laboratory April 30, 2009

Monitoring of Hadron Therapy by Means of Secondary Particles

Optimization of hadron therapy proton beam using Monte Carlo code on GPU

High Frequency Linacs for Hadrontherapy

Particle Therapy Accelerator Technology

ThomX Machine Advisory Committee. (LAL Orsay, March ) Ring Beam Dynamics

Status of PAMELA an overview of uk particle therapy facility using NS-FFAG

THE mono-energetic hadron beam such as heavy-ions or

A Dramatically Reduced Size in the Ganty Design for the Proton-Carbon Therapy. June Collider-Accelerator Department

Beam Optics for a Scanned Proton Beam at Loma Linda University Medical Center

COMPARISON OF COMPUTER CODES APPLICABILITY IN SHIELDING DESIGN FOR HADRON THERAPY FACILITIES *

M. Martišíková 1,3, C. Granja 2, J. Jakůbek 2, B. Hartmann 1,3, K. Gwosch 1, P. Soukup 2 and O. Jäkel 1,3,5

Physics 736. Experimental Methods in Nuclear-, Particle-, and Astrophysics. - Accelerator Techniques: Introduction and History -

Particle Accelerators for Research and for Medicine

Secondary Radiation and Shielding Design for Particle Therapy Facilities

Heavy ion fusion energy program in Russia

R&D of emulsion technology to study fragment interaction to improve ion therapy

Technological Challenges for High-Intensity Proton Rings

Thanks to all Contributors

Interactions of Particulate Radiation with Matter. Purpose. Importance of particulate interactions

Robust energy enhancement of ultra-short pulse laser accelerated protons from reduced mass targets

Section 4 : Accelerators

Engines of Discovery

Nuclear Physics and Hadrontherapy

SRF GUN CHARACTERIZATION - PHASE SPACE AND DARK CURRENT MEASUREMENTS AT ELBE*

Compton Scattering Effect and Physics of Compton Photon Beams. Compton Photon Sources around the World, Present and Future

Research Physicist Field of Nuclear physics and Detector physics. Developing detector for radiation fields around particle accelerators using:

FFA Accelerators Fixed Field Alternating Gradient

FFAG diagnostics and challenges

Accelerator and Beamline/Gantry Design from a user's point of view - for optimal beam delivery

Isotope Production for Nuclear Medicine

SPARCLAB. Source For Plasma Accelerators and Radiation Compton. On behalf of SPARCLAB collaboration

Direct-Current Accelerator

Biological Dose Calculations for Particle Therapy in FLUKA

Cyclotrons for Particle Therapy

Physics of particles. H. Paganetti PhD Massachusetts General Hospital & Harvard Medical School

Benchmark Experiments of Accelerator Driven Systems (ADS) in Kyoto University Critical Assembly (KUCA)

Secondary Neutron Dose Measurement for Proton Line Scanning Therapy

Measurements of secondary particles emitted by 12 C, 4 He and 16 O ion beams in view of innovative dose profiling technique in Particle Therapy

Performance Studies of the Vibration Wire Monitor on the Test Stand with Low Energy Electron Beam

Office of Science Perspective

Year 12 Notes Radioactivity 1/5

An Introduction to Plasma Accelerators

Transcription:

IVICFA Institut Valencià d Investigació Cooperativa en Física Avançada Miniworkshop on Medical Physics Accelerators for Hadrontherapy -- Present & Future -- Silvia Verdú-Andrés TERA / IFIC (CSIC-UV) Valencia, November 9th, 2012 1

Contents Basics on Hadrontherapy Present Accelerators for Hadrontherapy The Future and the Dreams

Basics on Hadrontherapy 3

Basics on Hadrontherapy What is hadrontherapy? Hadrontherapy is a type of external radiotherapy that uses beams of particles made of quarks (hadrons): neutrons, protons, pions, helium, lithium, boron, carbon, oxygen ions antiprotons hadrons electron atom quarks u or d carbon ion = 6p + 6n proton (p) or neutron (n)

Basics on Hadrontherapy Hadron beams in matter Depth-dose distribution Charged hadron beam that loses energy in matter Tumour target Courtesy of PSI o While passing through matter, a hadron loses most of its energy when it is almost stopped, at the so-called Bragg peak. o High doses can be delivered to tumour target while providing low doses to frontal and distal healthy tissue.

Basics on Hadrontherapy Hadron beams in matter 27 cm 200 MeV - 1 na protons 400 MeV/u 0.1 na carbon ions (radioresistant tumours) Courtesy of PSI o While passing through matter, a hadron loses most of its energy when it is almost stopped, at the so-called Bragg peak. o High doses can be delivered to tumour target while providing low doses to frontal and distal healthy tissue. o The position of the Bragg peak depends on the energy of the hadron at the volume entrance.

Basics on Hadrontherapy Physical properties of hadron beams i) Hadron beams spare healthy tissues while providing high doses to tumour volume 7

Basics on Hadrontherapy Physical properties of hadron beams i) Hadron beams spare healthy tissues while providing high doses to tumour volume 8

Basics on Hadrontherapy Physical properties of hadron beams i) Hadron beams spare healthy tissues while providing high doses to tumour volume 9

Basics on Hadrontherapy Physical properties of hadron beams ii) Dose delivery to 3D volume 10

Basics on Hadrontherapy Physical properties of hadron beams ii) Dose delivery to 3D volume e.g. SPOT SCANNING TECHNIQUE Guided narrow, focused beam of charged particles a) lateral scan: magnets b) depth scan: beam energy 11

Courtesy of U. Amaldi Basics on Hadrontherapy Radiobiological efficiency Physical properties (RBE) of carbon of hadron ion beams Better control of radioresistant tumours X-ray RBE = 1 Proton SSB Single Strand Break ionizations electron 2 nm chromosome

Courtesy of U. Amaldi Basics on Hadrontherapy Radiobiological efficiency Physical properties (RBE) of carbon of hadron ion beams Better control of radioresistant tumours X-ray Proton RBE = 1 Carbon ion RBE = 3 40 mm from the stopping point SSB Single Strand Break ionizations electron DSB Double Strand Break 2 nm chromosome 13

Basics on Hadrontherapy Physical and biological Physical properties of hadron beams i) Spare healthy tissues while providing high doses to tumoural volume ii) Dose delivery to 3D volume: guided narrow, focused beams of charged particles scanned (x,y) for different penetration depths (z) by changing the beam energy iii) Small diffusion 14

Basics on Hadrontherapy Physical and biological Physical properties of hadron beams i) Spare healthy tissues while providing high doses to tumoural volume ii) Dose delivery to 3D volume: guided narrow, focused beams of charged particles scanned (x,y) for different penetration depths (z) by changing the beam energy iii) Small diffusion Proton and carbon ion therapy allow Conformal treatment of deep-seated tumours with milimeter accuracy Carbon ions allow Better control of radioresistant tumours 15

Basics on Hadrontherapy Number of potential patients* X-ray therapy Protontherapy every 10 million inhabitants: 20 000 pts/year 12% of X-ray patients: 2 400 pts/year Therapy with Carbon ions for radio-resistant tumours 3% of X-ray patients: 600 pts/year TOTAL about 3 000 pts/year (every 10 M) * ENLIGHT (FP5) outcome: studies carried out in Austria, Germany, Italy and France 16

Basics on Hadrontherapy Treating moving organs requires e.g. SPOT SCANNING TECHNIQUE 18

Basics on Hadrontherapy Treating moving organs requires a) lateral scan: magnets 2 ms/step b) depth scan: beam energy few ms Fast Active Energy Modulation (a couple of ms) To perform a fast change of beam spot position in depth 19

Basics on Hadrontherapy Treating moving organs requires 200-300 Hz Fast Active Energy Modulation (a couple of ms) To perform a fast change of beam spot position in depth Fast Cycling machine Tumour MULTIPAINTING (high repetition rate ~ 200-300 Hz) 20

Present Accelerators for Hadrontherapy 21

Hadrontherapy in the world Present accelerators for hadrontherapy Nowadays 35 facilities all around the world offer protontherapy (cyclotron or synchrotron*-based facilities) and 6 centers provide carbon ion therapy (only synchrotron-based facilities)

* Commercial solutions available! (mainly protons): IBA, Varian, Mitsubishi, Hitachi, Hadrontherapy in the world Present accelerators for hadrontherapy Nowadays 35 facilities all around the world offer protontherapy (cyclotron or synchrotron*-based facilities) and 6 centers provide carbon ion therapy (only synchrotron-based facilities)

Hadrontherapy in the world Typical Proton Therapy Facility Beam Transport 4 m Cyclotron Irradation systems: Fixed Irradation systems: Rotating Gantries 24

Hadrontherapy in the world Proton Therapy Facility A Proton therapy system is much more than an accelerator: it is most often a complex, multi-room treatment system The treatments rooms are larger than the cyclotron/synchrotron vault About one third of the total investment is for the accelerator; the rest is for the building, equipment, etc. 25

Hadrontherapy in the world Cyclotrons for Proton Therapy In the 90 s the consensus was that the best accelerator for protontherapy was a synchrotron 26

Hadrontherapy in the world Cyclotrons for Proton Therapy In the 90 s the consensus was that the best accelerator for protontherapy was a synchrotron However today most protontherapy centers use cyclotron technology (IBA, Varian, Still Rivers ) 27

Hadrontherapy in the world Cyclotrons for Proton Therapy In the 90 s the consensus was that the best accelerator for protontherapy was a synchrotron However today most protontherapy centers use cyclotron technology (IBA, Varian, Still Rivers ) Over these 15 years, users appreciated advantages of cyclotrons: Simplicity Reliability Lower cost and size Most importantly: rapid and accurate proton beam current modulation 28

Hadrontherapy in the world Cyclotrons for Proton Therapy In the 90 s the consensus was that the best accelerator for protontherapy was a synchrotron However today most protontherapy centers use cyclotron technology (IBA, Varian, Still Rivers ) Over these 15 years, users appreciated advantages of cyclotrons: Simplicity Reliability Lower cost and size Most importantly: rapid and accurate proton beam current modulation but cyclotrons deliver a fixed energy beam so absorbers needed to vary the beam energy 29

Hadrontherapy in the world Synchrotrons for Proton Therapy Advantages: Variable energy operation Modified Flat-Top operation Easy dose management Synchrotrons deliver a pulsed beam 30

Hadrontherapy in the world Synchrotrons for Proton Therapy Advantages: Variable energy operation Modified Flat-Top operation Easy dose management Relatively low intensity Some protontherapy centers use the synchrotron technology (Hitachi, Mitsubishi ), but all the ion beam centers (p, C) use synchrotron Possibility of proton&carbon therapy with the same accelerator 31

Hadrontherapy in the world Typical Synchrotron-based Proton Facility 32

~ 13 m Hadrontherapy in the world Protons and helium, oxygen and carbon ions Ion Beam Facility Beam Transport Lines Ion Sources Synchrotron LINAC Treatment Halls by Siemens Gantry Heidelberg Ion Therapy (HIT) ~ 600 tones

Hadrontherapy in the world Key issue: compact gantries Gantry: beam line that directs and focuses the beam onto the patient at whatever angle is required for the treatment plan optimization.

~ 8 m Hadrontherapy in the world Key issue: compact gantries Protons e.g. PSI gantry-2 ~ 100 tones ~ 12 m

~ 13 m Hadrontherapy in the world Key issue: compact gantries Carbon ions HIT gantry (unique worldwide) Beam Transport Lines Ion Sources Synchrotron LINAC Treatment Halls by Siemens Gantry Heidelberg Ion Therapy (HIT) ~ 600 tones

Future Accelerators for Hadrontherapy 37

Hadrontherapy in the world Present accelerators for hadrontherapy Cyclotrons: compact, reliable, easy to operate however fixed energy beam movable absorbers long Energy Selection System line neutron activation and carbon fragmentation energy modulation in 80-100 ms Synchrotrons: variable energy beam but energy modulation in 1-2 s

Hadrontherapy in the world Protontherapy (200-250 MeV protons) Present accelerators for hadrontherapy Carbontherapy (400 MeV/u carbon ions) [M. Shippers, PSI]

The existance of compact, reliable accelerators with advanced beam performances would facilitate the access to hadrontherapy to more patients. Compact gantries are needed!

Future Accelerators for Hadrontherapy Cyclotron for carbon ion therapy C400, about 6.3 m-diameter, superconducting coils Courtesy of IBA 41

Future Accelerators for Hadrontherapy The cyclinac: cyclotron + high frequency linac Courtesy of TERA Cell Coupled Linac Standing-wave structure RF frequency: 5.7 GHz 2.5 ms-long pulse at 300 Hz CABOTO (CArbon BOoster for Therapy in Oncology)

Future Accelerators for Hadrontherapy A compact gantry based on the cyclinac idea Courtesy of TERA C-band linac Section 1 C-band linac Section 2 W 1 SM 1 cyclotron W 0 W 2 Line with 2% momentum acceptance RF Power sources RF rotating joints SM 2 Beam dose delivery Cell Coupled Linac Standing-wave structure RF frequency: 5.7 GHz 2.5 ms-long pulse at 100 Hz TULIP (TUrning LInac for Protontherapy)

Future Accelerators for Hadrontherapy SLAC X-band Proton Therapy Solution 45

Future Accelerators for Hadrontherapy Cyclotron mounted on gantry Monarch 250, courtesy of Still River 46

Future Accelerators for Hadrontherapy FFAGs - Fixed-Field Alternating-Gradient accelerators Ring of magnets like synchrotron, fixed field like cyclotron Dense lattice of EMMA, the first NS-FFAG 47 (for electron acceleration) Courtesy of C. Johnstone

The Cyclinac Machine Performances: Compactness done to scale!

Far future Accelerators for Hadrontherapy 49

Future Accelerators for Hadrontherapy Dielectric Wall Accelerator (DWA) Typical induction cell 50

Future Accelerators for Hadrontherapy Laser-driven proton beam therapy Foil Laser Courtesy of JAEA Photo-Medical Research Center (PMRC) azimutal magnetic field ion beam 51

Summary 55

Accelerators for Hadrontherapy Requirements Beam Parameter Min./Max. Extraction Energy [MeV/u] (range variation: 3-32 cm) Beam Intensity [na] (average dose rate: 2 Gy/min/L) Repetition Rate [Hz] (+ fast scanning (in miliseconds) ) to treat moving organs Value 60/230 (protons) 110/430 (carbon ions) 1 (protons) 0.1 (carbon ions) 200-300 Preferably, energy modulation without absorbers In addition reduced size and cost 56

Hadrontherapy in the world Present accelerators for hadrontherapy Cyclotrons: compact, reliable, easy to operate however fixed energy beam movable absorbers long Energy Selection System line neutron activation and carbon fragmentation energy modulation in 80-100 ms Synchrotrons: variable energy beam but energy modulation in 1-2 s

Novel Accelerators for Hadrontherapy different accelerator types have been proposed Close to realization Fixed-Field Alterning-Gradient (FFAG) accelerators: high-repetition rate (~ khz), active energy modulation but so far not so compact challenging injection and extraction systems (dense lattice!) Cyclinacs (cyclotron + RF linac): high-repetition rate (~ khz), active energy modulation Long-term candidates Dielectric Wall Accelerators (DWA): Compact if required accelerating gradients are achieved (1 100 MV/m) Laser-driven accelerators: Is it possible to get clean, monoenergetic beams?

Some material belongs to Ángeles Faus-Golfe, Present & Future of Accelerators for Hadrontherapy, IFIMED 09 symposium, June 2009, Valencia (Spain) Ugo Amaldi, Particle Accelerators in Diagnostics and Cancer Therapy (Madrid 2009): http://www.ft.uam.es/pdfs/amaldi_slides.pdf David Robin, An Overview of Next Generation Gantries, 2nd Workshop on Hadron Beam Therapy (Erice 2011): http://erice2011.na.infn.it/talkcontributions/robin.pdf Silvia Verdú-Andrés, Comparison between RF linacs and FFAGs for hadrontherapy, PARTNER deliverable (2011). Silvan Zenklusen, Feasibility of Simulated Scattering on a Scanning Gantry for Proton Radiation Therapy, Indico slides (2009).

Bibliography GAP (Group of Accelerator Physics) of IFIC (project leader: Ángeles Faus-Golfe): http:\\gap.ific.uv.es U. Linz and J. Alonso, What will it take for laser driven proton accelerators to be applied to tumor therapy?, Physical Review Special Topics Accelerators and Beams, Volume 10 (9) American Physical Society (APS) Sep 1, 2007 S. Verdu-Andres, High-Gradient RF Structure Studies and their Application in Hadrontherapy, PhD thesis, University of Valencia (under submission, 2012). S. Verdu-Andres, Comparison of RF Linacs and FFAGs for Hadrontherapy. Third PARTNER deliverable of WP25 for the European Union under grant agreement number 215840-2 within the Seventh Framework Programme [FP7/2007-2013], Geneva, Switzerland (2011). Thanks for your attention 60